Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
Angelo BelottiRossella RibollaValeria CancelliAlberta VillanacciValentina AngeliniMarco ChiariniViviana GiustiniGiulia V FacchettiAldo M RoccaroSamantha FerrariAnnalisa PeliChiara BottelliChiara CattaneoClaudia CrippaMonica MicilottaBarbara FrittoliLuigi GrazioliGiuseppe RossiAlessandra TucciPublished in: Cancer medicine (2021)
The present study supports the applicability of MY-RADS recommendations after ASCT; RAC criteria were able to independently stratify patients and to better predict their prognosis and the combined use of DW-MRI with MFC allowed a more precise evaluation of MRD.
Keyphrases
- contrast enhanced
- diffusion weighted
- stem cell transplantation
- magnetic resonance imaging
- flow cytometry
- magnetic resonance
- end stage renal disease
- diffusion weighted imaging
- computed tomography
- high dose
- multiple myeloma
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- high resolution
- peritoneal dialysis
- clinical practice
- stem cells
- patient reported outcomes
- cell therapy
- fluorescence imaging
- mass spectrometry
- patient reported